Wilmer Cutler Pickering Hale and Dorr advised Trevi Therapeutics, Inc., and Covington & Burling advised the underwriters.Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company, announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
